Protagenic Therapeutics Inc (PTIX)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -138.149 | -91.442 | -206.457 | -227.55 | -296.223 | -75.768 | -37.241 | -80.906 |
Return on Equity (%) | -238.825 | -122.294 | -507.54 | 414.438 | 285.762 | -102.889 | -42.183 | -94.464 |
Return on Invested Capital (%) | -151.177 | -127.976 | -459.127 | 737.102 | 3896.183 | -78.997 | -41.425 | -85.528 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.001 | N/A | N/A | N/A | N/A | 0.002 | 0.001 | 0.001 |
Earnings Per Share | N/A | N/A | -0.001 | N/A | -0.001 | -0.001 | -0.001 | -0.001 |
Cash Per Share | 0.001 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | 0.001 | N/A | N/A | N/A | N/A | 0.002 | 0.001 | 0.001 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | -0.001 | N/A | -0.001 | -0.001 | -0.001 | -0.001 |
EBITDA Per Share | N/A | N/A | -0.001 | N/A | -0.001 | -0.001 | -0.001 | -0.001 |
Free Cash Flow Per Share | N/A | N/A | -0.001 | N/A | -0.001 | -0.001 | -0.001 | -0.001 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 7.61M | 10.26M | 10.26M | 10.26M | 10.36M | 17.21M | N/A | 4.44M |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | 4.32M | N/A | N/A | 4.44M | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 3.67M |
Price to Earnings Ratio | -0.71 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.74 |
Price to Book Ratio | 0.96 |
Dividend Yield | - |
Shares Outstanding | 6.79M |
Average Volume (1 week) | 293.37k |
Average Volume (1 Month) | 454.46k |
52 Week Change | -30.11% |
52 Week High | 1.87 |
52 Week Low | 0.4515 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.